Day One Biopharmaceuticals’ Post

Day One welcomes the Pediatric Neuro-Oncology community to ISPNO! Connect with peers at our reception and hear from Day One leaders on the collaboration between academia and industry in advancing pediatric drug development. Learn more and register here: https://bit.ly/3xxJ6CC

Day One is thrilled to be featured in Times Square today! The expansion of our pipeline with DAY301 is an exciting milestone to further our mission to bring ground-breaking treatments to people of all ages with cancer.

Our teams are looking forward to participating in the ISPNO Annual Meeting in Philadelphia! Stop by booth 1 to learn more about our work in pediatric drug development.

Today, we announced the expansion of our pipeline with a clinical-stage antibody drug conjugate (ADC) targeting PTK7 in solid tumors for adult and pediatric cancers. DAY301 is an important continuation of our mission to transform outcomes for patients of all ages living with cancers. Learn more: https://lnkd.in/gg_jwggu

We recently published a framework for multistakeholder collaboration in pediatric cancer research and drug development based upon a case study of the tovorafenib journey. Co-authored by colleagues and collaborators, the framework specifies roles and responsibilities for effective collaboration between industry, academia, and non-profit organizations to bring new hope to children with cancer and their families. See the highlights below and access the full white paper here: https://bit.ly/4bYoLF7

It's great to be back at ASCO! Visit Day One at booth 34143 to say hello and learn more about how we are addressing the critical unmet need for children with brain tumors. #ASCO24

We're gearing up for this year's American Society of Clinical Oncology (ASCO) Annual Meeting and we're excited to see everyone in Chicago! If you're attending #ASCO24, stop by booth 34143 to meet the Day One team and learn more about how we're bringing novel targeted therapies to children with brain tumors.

#ICYMI catch part two of this webinar with personal advice on how to best advocate for children with pediatric low-grade glioma (#pLGG). Watch here: https://bit.ly/4bnInCT

This past weekend, some of our Denver-based Day One team members came together to participate in the local 2nd Annual Tumor Trot. Supporting the fight against childhood brain tumors is a cause we deeply believe in. #BrainTumorAwareness #BTAM #GoGrayinMay